Table 3 Laboratory findings of 226 patients with COVID-19 in ICUs
From: Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
Characteristics | All patients (n = 226) |
|---|---|
Blood routine | |
 White blood cell count (×109 per L; normal range 4–10) | 8.54 (5.89–12.69) |
  Increased | 95 (42.0%) |
  Decreased | 16 (7.1%) |
 Hematocrit (%) | 31.1 (26.3–35.7) |
 Hemoglobin (g/L; normal range 130–175) | 98 (85–116) |
  Decreased | 220 (97.3%) |
 Neutrophils (×109 per L; normal range 1.8–6.3) | 7.28 (4.24–10.94) |
  Increased | 127 (56.2%) |
  Decreased | 4 (1.8%) |
 Lymphocytes (×109 per L; normal range 1.1–3.2) | 0.84 (0.56–1.19) |
  Increased | 1 (0.4%) |
  Decreased | 160 (70.8%) |
 Platelets (×109 per L; normal range 125–350) | 181.5 (115–258) |
  Increased | 14 (6.2%) |
  Decreased | 66 (29.2%) |
Coagulation panel (n = 223) | |
 Prothrombin time (s; normal range 11–16) | 13 (11.6–14.7) |
  > 16 to ≤ 19 | 19 (8.5%) |
  > 19 | 11 (4.9%) |
 Activated partial thromboplastin time (s; normal range 28–43.5) | 32.3 (26.1–42.1) |
  > 43.5 to ≤ 48.5 | 17 (7.6%) |
  > 48.5 | 34 (15.2%) |
 D-dimer (n = 212) (mg/L; normal range < 0.5) | 3 (1.2–7.1) |
  > 0.5 to ≤ 1 | 20 (9.4%) |
  > 1 | 169 (79.7%) |
Hepatic function | |
 Glutamic pyruvic transaminase (U/L; normal range < 40) | 31.2 (19–57) |
  Increased | 85 (37.6%) |
 Glutamic oxalacetic transaminase (U/L; normal range < 50v) | 31.6 (22–48) |
  Increased | 46 (20.4%) |
 Total bilirubin concentration (μmol/L, normal range 3–22) | 12.6 (8.6–19.1) |
  Increased | 42 (18.6%) |
 Albumin concentration (g/L, normal range 35–50) | 32.8 (29.4–36.9) |
  Decreased | 145 (64.2%) |
Renal function | |
 Serum creatinine concentration (μmol/L, normal range 46–92) | 64.2 (49–111.6) |
  Increased | 70 (31.0%) |
 Blood urea nitrogen (mmol/L, normal range 2.5–6.1) | 7.34 (5.2–14.1) |
  Increased | 140 (61.9%) |
Serum electrolyte | |
 Potassium (mmol/L, normal range 3.5–5.1) | 4.1 (3.7–4.56) |
 Sodium (mmol/L, normal range 135–145) | 140 (137–144) |
Myoglobin plasma concentration (n = 162) (ng/mL, normal range < 150) | |
 < 150 | 105 (64.8%) |
 ≥ 150 to < 1000 | 47 (29.0%) |
 ≥ 1000 | 10 (6.2%) |
Procalcitonin (n = 220) (ng/mL, normal range < 0.05) | 0.19 (0.05–1.4) |
 < 0.05 | 58 (26.4%) |
 0.05–0.5 | 80 (36.4%) |
 > 0.5 | 82 (37.3%) |
Ferritin concentration (n = 122) (μg/L, normal range < 500) | |
 < 500 | 31 (25.4%) |
 ≥ 500 to < 1000 | 33 (27.1%) |
 ≥ 1000 to < 1500 | 17 (13.9%) |
 ≥ 1500 to < 2000 | 10 (8.2%) |
 ≥ 2000 | 31 (25.4%) |